LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

CerTest Biotec Opens New Facility for Diagnostic Products

By LabMedica International staff writers
Posted on 31 May 2018
CerTest Biotec (Zaragoza, Spain), a biotechnology company focused on the development and manufacturing of IVD diagnostic products, has opened a new facility in Spain for the research, development and manufacture of molecular diagnostics products.

CerTest develops, manufactures and sells a wide range of products for the identification of the agents causing infectious diseases in health facilities, laboratories and hospitals. The company develops and provides clinical diagnostics products with high standards of quality, sensitivity, specificity and reproducibility, allowing the identification of pathogens at early stages of infection. It also collaborates with a large number of hospitals and research institutes in Spain and abroad.

Image: CerTest Biotec has opened a new facility in Spain for R&D and manufacture of molecular diagnostics products (Photo courtesy of CerTest Biotec).
Image: CerTest Biotec has opened a new facility in Spain for R&D and manufacture of molecular diagnostics products (Photo courtesy of CerTest Biotec).

The new facility, with a surface area of 4,500 square meters, comprises state-of-the-art laboratories, offices, warehouse and production and quality control areas, among others and has been set up at an investment of 5 million Euros. With this facility, CerTest Biotec will now have a total floor space of 7,000 square meters and will continue to expand in the field of molecular biology, which is one of the company’s specialties.

Related Links:
CerTest Biotec


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Hematology Consumables
Bioblood Devices

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
31 May 2018  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
31 May 2018  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
31 May 2018  |   Industry